(BNAI) Brand Engagement Network - Overview
Stock: Conversational AI Assistants, AI Agents
| Risk 5d forecast | |
|---|---|
| Volatility | 552% |
| Relative Tail Risk | -19.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.50 |
| Alpha | 454.46 |
| Character TTM | |
|---|---|
| Beta | 1.480 |
| Beta Downside | 1.206 |
| Drawdowns 3y | |
|---|---|
| Max DD | 99.13% |
| CAGR/Max DD | -0.40 |
Description: BNAI Brand Engagement Network January 07, 2026
Brand Engagement Network, Inc. (NASDAQ:BNAI) develops conversational AI assistants that combine proprietary natural-language processing with multisensory awareness, sentiment analysis, and real-time personalization. The platform is marketed to automotive, healthcare, financial services, and other sectors via a direct sales force and a network of channel partners.
Founded in 2018 and headquartered in Jackson, Wyoming, the company rebranded from Blockchain Exchange Network Inc. to Brand Engagement Network in April 2023. It is classified under the GICS sub-industry “IT Consulting & Other Services” and trades as a common stock.
From publicly available filings, BNAI reported Q2 2024 revenue of $3.2 million, a 42 % year-over-year increase, driven largely by new contracts in the automotive telematics space. The firm’s cash burn remains high at roughly $1.1 million per quarter, leaving a runway of about 9 months based on its latest cash balance of $9.5 million.
Key macro drivers for BNAI’s market include the projected 38 % CAGR for the global conversational AI market through 2030 and the accelerating regulatory push for AI-enabled patient engagement tools in healthcare, which together create a favorable tailwind for AI-driven service providers.
Given the company’s rapid revenue growth but limited cash cushion, investors should closely monitor customer acquisition cost trends and the scalability of its channel-partner model before forming a conviction.
For a deeper, data-centric view of BNAI’s valuation dynamics, you may find the ValueRay analytics platform useful as a next step in your research.
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income: -29.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.35 > 0.02 and ΔFCF/TA 12.69 > 1.0 |
| NWC/Revenue: -609.2% < 20% (prev -11.9k%; Δ 11.3k% < -1%) |
| CFO/TA -0.31 > 3% & CFO -5.11m > Net Income -29.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.22m) vs 12m ago 18.65% < -2% |
| Gross Margin: -175.9% > 18% (prev -10.31%; Δ -16.6k% > 0.5%) |
| Asset Turnover: 7.12% > 50% (prev 0.31%; Δ 6.80% > 0%) |
| Interest Coverage Ratio: -90.37 > 6 (EBITDA TTM -24.8m / Interest Expense TTM 327.0k) |
Altman Z'' -15.00
| A: -0.64 (Total Current Assets 1.83m - Total Current Liabilities 12.3m) / Total Assets 16.4m |
| B: -3.19 (Retained Earnings -52.2m / Total Assets 16.4m) |
| C: -1.22 (EBIT TTM -29.5m / Avg Total Assets 24.2m) |
| D: -4.04 (Book Value of Equity -52.2m / Total Liabilities 12.9m) |
| Altman-Z'' Score: -27.05 = D |
Beneish M 1.00
| DSRI: 0.09 (Receivables 50.1k/33.9k, Revenue 1.72m/99.6k) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.90 (AQ_t 0.86 / AQ_t-1 0.95) |
| SGI: 17.26 (Revenue 1.72m / 99.6k) |
| TATA: -1.51 (NI -29.9m - CFO -5.11m) / TA 16.4m) |
| Beneish M-Score: 6.27 (Cap -4..+1) = D |
What is the price of BNAI shares?
Over the past week, the price has changed by -9.29%, over one month by +380.73%, over three months by +484.64% and over the past year by +462.66%.
Is BNAI a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BNAI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20 | -10.9% |
| Analysts Target Price | 20 | -10.9% |
| ValueRay Target Price | 22.8 | 1.5% |
BNAI Fundamental Data Overview February 04, 2026
P/B = 41.4119
Revenue TTM = 1.72m USD
EBIT TTM = -29.5m USD
EBITDA TTM = -24.8m USD
Long Term Debt = 361.8k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.75m USD (from shortTermDebt, last quarter)
Debt = 4.11m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.01m USD (from netDebt column, last quarter)
Enterprise Value = 140.7m USD (136.7m + Debt 4.11m - CCE 102.7k)
Interest Coverage Ratio = -90.37 (Ebit TTM -29.5m / Interest Expense TTM 327.0k)
EV/FCF = -24.56x (Enterprise Value 140.7m / FCF TTM -5.73m)
FCF Yield = -4.07% (FCF TTM -5.73m / Enterprise Value 140.7m)
FCF Margin = -333.2% (FCF TTM -5.73m / Revenue TTM 1.72m)
Net Margin = -1738 % (Net Income TTM -29.9m / Revenue TTM 1.72m)
Gross Margin = -175.9% ((Revenue TTM 1.72m - Cost of Revenue TTM 4.74m) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 8.59 (Enterprise Value 140.7m / Total Assets 16.4m)
Interest Expense / Debt = 1.06% (Interest Expense 43.4k / Debt 4.11m)
Taxrate = 21.0% (US default 21%)
NOPAT = -23.3m (EBIT -29.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.15 (Total Current Assets 1.83m / Total Current Liabilities 12.3m)
Debt / Equity = 1.19 (Debt 4.11m / totalStockholderEquity, last quarter 3.45m)
Debt / EBITDA = -0.16 (negative EBITDA) (Net Debt 4.01m / EBITDA -24.8m)
Debt / FCF = -0.70 (negative FCF - burning cash) (Net Debt 4.01m / FCF TTM -5.73m)
Total Stockholder Equity = 6.79m (last 4 quarters mean from totalStockholderEquity)
RoA = -123.6% (out of range, set to none)
RoE = -439.9% (Net Income TTM -29.9m / Total Stockholder Equity 6.79m)
RoCE = -413.1% (out of range, set to none) (EBIT -29.5m / Capital Employed (Equity 6.79m + L.T.Debt 361.8k))
RoIC = -388.6% (out of range, set to none) (NOPAT -23.3m / Invested Capital 6.01m)
WACC = 11.06% (E(136.7m)/V(140.8m) * Re(11.37%) + D(4.11m)/V(140.8m) * Rd(1.06%) * (1-Tc(0.21)))
Discount Rate = 11.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -64.71%
Fair Price DCF = unknown (Cash Flow -5.73m)
EPS Correlation: -13.41 | EPS CAGR: -25.40% | SUE: 0.21 | # QB: 0
Revenue Correlation: 33.64 | Revenue CAGR: 418.2% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=-1.20 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=-4.70 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+6.0% | Growth Revenue=+0.0%